Scott D. Morenstein, Director at Celator Pharmaceuticals Inc (CPXX), bought 5,000 shares at $1.87 ($9K) on 2015-12-03, disclosed to the SEC on 2015-12-07.
Open-market purchase of $9k CPXX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |